BG
SAGE

BlackRock Group’s Sage Therapeutics SAGE Stock Holding History

BlackRock Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.31M Buy
103,956
+8,889
+9% +$419K ﹤0.01% 1159
2016
Q3 		$4.38M Buy
95,067
+31,517
+50% +$1.28M ﹤0.01% 1169
2016
Q2 		$1.92M Buy
63,550
+56,642
+820% +$1.89M ﹤0.01% 1581
2016
Q1 		$222K Buy
6,908
+2,875
+71% +$101K ﹤0.01% 2537
2015
Q4 		$235K Sell
4,033
-104
-3% -$5.15K ﹤0.01% 2473
2015
Q3 		$175K Buy
4,137
+830
+25% +$51.1K ﹤0.01% 2565
2015
Q2 		$241K Buy
+3,307
New +$213K ﹤0.01% 2527
2015
Q1 		– Sell
-18,562
Closed -$679K – 2880
2014
Q4 		$679K Buy
18,562
+300
+2% +$11.2K ﹤0.01% 2104
2014
Q3 		$576K Buy
+18,262
New +$529K ﹤0.01% 2107

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return